LRMR
Larimar Therapeutics Inc
$3.13
0.08 (2.46%) Today
— up— down
Market Cap
$317M+9.4%
Revenue (TTM)
$0
$0Net Income (TTM)
$-216,101,564
$-216,101,564EPS (TTM)
-2.08
-2.08Shares Out
103.88M
103.88MOpen
$3.05
$3.05Previous Close
$3.05
$3.05Day Range
$3.01 – $3.25
$3.01 – $3.2552-Week Range
$2.72 – $6.42
$2.72 – $6.42Beta
0.85
0.85Earnings Date
Aug 12, 2026
Aug 12, 2026Volume
1.76M
1.76MAvg Volume
3.87M
3.87MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout LRMR
Related
News
Larimar Therapeutics, Inc. (LRMR) Discusses Regulatory Progress and Long-Term Data for Nomlabofusp in Friedreich's Ataxia - Slideshow
SeekingAlpha · 11h ago
Baird Maintains Outperform on Larimar Therapeutics, Lowers Price Target to $5
Benzinga · 1d ago
Larimar Therapeutics, Inc. (LRMR) Discusses Regulatory Progress and Long-Term Data for Nomlabofusp in Friedreich's Ataxia Transcript
SeekingAlpha · 2d ago
Larimar Stock Slides 15% Despite FDA Backing Rolling Submission For Rare Disease Drug
Benzinga · 2d ago
Larimar Therapeutics Submits First Module Of Rolling BLA Submission To FDA For Accelerated Approval Of Nomlabofusp; Remaining Modules Expected To Be Submitted In H2 2026
Benzinga · 2d ago